Dyne Therapeutics: Funding, Investors & Team (Sep 2026)
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's therapies deliver nucleic acids and other molecules to skeletal, cardiac and smooth muscle with unprecedented precision, enabling patients to restore muscle strength and transform their lives.
Dyne Therapeutics has raised $200M across 1 funding round on record, the most recent an undisclosed round of $200M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Dyne Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Dyne Therapeutics Funding Rounds
Dyne Therapeutics Founders and Leadership Team
Contact details for the Dyne Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Dyne Therapeutics Funding Compared to Other Biotechnology Startups
Dyne Therapeutics' latest round of $200M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Dyne Therapeutics in Biotechnology and Cambridge
Companies Similar to Dyne Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Dyne Therapeutics Funding FAQs
What does Dyne Therapeutics do?
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's therapies deliver nucleic acids and other molecules to skeletal, cardiac and smooth muscle with unprecedented precision, enabling patients to restore muscle strength and transform their lives.
How much funding has Dyne Therapeutics raised?
Dyne Therapeutics has raised $200M across 1 round on record. The most recent is an undisclosed round of $200M announced in Jun 2026.
When did Dyne Therapeutics last raise funding?
Dyne Therapeutics' most recent funding round on record is an undisclosed round of $200M, announced in Jun 2026.
Who founded Dyne Therapeutics?
FundedIQ lists John Cox (Founder) at Dyne Therapeutics.
Where is Dyne Therapeutics headquartered?
Dyne Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Dyne Therapeutics have?
Dyne Therapeutics is in the 101-250 employee band.
How does Dyne Therapeutics' funding compare to other Biotechnology startups?
Dyne Therapeutics' latest round of $200M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Dyne Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Dyne Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.